FDAImports.com Assists Companies with Prop 65, Safe Cosmetics Act and California Compliance and Litigation Defense in New Irvine, California Office
In addition to its corporate headquarters near Baltimore, Maryland, FDA consulting firm, FDAImports.com has opened another office in Irvine, California in an effort to assist current and future clients with the challenges stemming from California’s unique regulatory...
New Legislation Imposes Document Reviews, Risk-Based Drug Inspections and Increased Drug Listing & Drug Registration Requirements
The Food and Drug Administration Safety and Innovation Act (S. 3187) was signed into law by President Obama on July 9th of this year. The Act brings numerous changes for the drug and medical device industry but all of the attention so far has been on the Prescription...
Exhibiting and Presenting at Natural Products Expo Asia 2012 in Hong Kong
The FDAImports.com and ExportToUsa.com.cn Team will be exhibiting at the 2012 Natural Products Expo Asia in Hong Kong on August 23 – 25, 2012. In addition to exhibiting at one of Asia’s largest natural products events, Rick Quinn, Principal at FDAImports.com will be...
FDAImports.com Gets Chinese Company Removed From FDA Import Alert 53-17, Microbiological Contamination in Cosmetics
FDA consulting firm, FDAImports.com, has won another substantial victory for a client on FDA Import Alert, this time for Import Alert 53-17, Detention Without Physical Examination of Cosmetics Due to Microbiological Contamination. A Chinese company bringing in eye...
Will FDA Meet its July 4 FSMA Deadline? Don’t Hold Your Breath
It’s that time of year again… Time for another FSMA deadline! The pressure is on for the U.S. Food and Drug Administration to meet yet another critical date with multiple deadlines imposed by the Food Safety Modernization Act (FSMA). Every 6 months a deadline rolls...
How an FDA Inspection Can Fuel a Consumer Lawsuit
The following is a letter from FDAImports.com Founder and CEO, Benjamin England: As you may know, Diamond Pet Food Processors issued multiple product recalls over the last two months. On April 12, only six days after Diamond's first recall, FDA conducted a weeklong...
FDA and Nanotech Regulation: The Smaller it is, the Longer it Takes
Apparently, the smaller something is, the longer it takes to talk about. This is the axiom currently employed by FDA, illustrated by the agency’s recently published guidance on nanomaterials in cosmetics and foods (5 years in the making). While the European Union...
Rick Quinn & John Johnson Author FDLI Article, “FDA’s Illegal Treatment of Brazilian Orange Juice During the Carbendazim Incident”
Did the U.S. Food and Drug Administration act illegally, capriciously and arbitrarily in its treatment of imported orange juice during the carbendazim incident? This is the question that FDAImports.com Principal, Rick Quinn, and Associate Attorney, John Johnson,...
Steven A. Johnson Joins the FDAImports.com Team
The FDAImports.com team is pleased to welcome Steven A. Johnson to our team! Mr. Johnson joins the firm as Principal, bringing nearly 20 years of FDA, Pharmaceutical, Biotech and Medical Device experience to the firm. He will be assisting clients with biotech and...
Benjamin England Presents on FSMA Time Bombs: The Sleeper Provisions in FSVP, Bioterrorism, Import Alerts, HARPC and International Trade
FDAImports.com Founder and CEO, Benjamin England, recently presented a webinar with FXConferences entitled “FSMA Time Bombs: The Sleeper Provisions and How to Prepare.” This webinar addressed numerous provisions within the Food Safety Modernization Act that are not...